This is a contrast between INSYS Therapeutics Inc. (NASDAQ:INSY) and Otonomy Inc. (NASDAQ:OTIC) based on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. The two companies are Biotechnology and they also compete with each other.
Earnings and Valuation
Table 1 highlights INSYS Therapeutics Inc. and Otonomy Inc.’s top-line revenue, earnings per share (EPS) and valuation.
Table 2 has INSYS Therapeutics Inc. and Otonomy Inc.’s return on equity, net margins and return on assets.
Risk and Volatility
INSYS Therapeutics Inc. has a 2.56 beta, while its volatility is 156.00%, thus making it more volatile than SP 500. Competitively, Otonomy Inc. is 149.00% more volatile than SP 500, because of the 2.49 beta.
In next table is given INSYS Therapeutics Inc. and Otonomy Inc.’s ratings and recommendations.
$7.75 is INSYS